Terms: = Head and neck cancer AND ZNF521, EHZF, 25925, ENSG00000198795, MGC142208, MGC142182, DKFZp564D0764, Evi3 AND Treatment
1 results:
1. Cetuximab promotes epithelial to mesenchymal transition and cancer associated fibroblasts in patients with head and neck cancer.
Schmitz S; Bindea G; Albu RI; Mlecnik B; Machiels JP
Oncotarget; 2015 Oct; 6(33):34288-99. PubMed ID: 26437222
[TBL] [Abstract] [Full Text] [Related]
